TY - JOUR
T1 - Restoring pulmonary and sleep services as the COVID-19 pandemic lessens
AU - Wilson, Kevin C.
AU - Kaminsky, Davida
AU - Gaetanemi, Chaud
AU - Sharma, Sunil
AU - Nici, Linda
AU - Folz, Rodney
AU - Barjaktarevic, Igor
AU - Bhakta, Nirav R.
AU - George, Cheng
AU - Lchupp, Geoffrey
AU - Cole, Adam
AU - Dixon, Annee
AU - Finigan, James H.
AU - Graham, Brian
AU - Hallstrand, Teal S.
AU - Haynes, Jeffrey
AU - Hankinson, John
AU - MacIntyre, Neil
AU - Mandel, Jess
AU - McCarthy, Kevin
AU - McCormack, Meredith
AU - Patil, Susheel P.
AU - Rosenfeld, Margaret
AU - Senitko, Michal
AU - Sethi, Sonali
AU - Swenson, Erik R.
AU - Stanojevic, Sanja
AU - Teodorescu, Mihaela
AU - Weiner, Daniel J.
AU - Wiener, Renda Soylemez
AU - Powell, Charles A.
N1 - Publisher Copyright:
Copyright © 2020 by the American Thoracic Society.
PY - 2020/11
Y1 - 2020/11
N2 - In March 2020, many elective medical services were canceled in response to the coronavirus disease 2019 (COVID-19) pandemic. The daily case rate is now declining in many states and there is a need for guidance about the resumption of elective clinical services for patients with lung disease or sleep conditions. Methods: Volunteers were solicited from the Association of Pulmonary, Critical Care, and Sleep Division Directors and American Thoracic Society. Working groups developed plans by discussion and consensus for resuming elective services in pulmonary and sleep-medicine clinics, pulmonary function testing laboratories, bronchoscopy and procedure suites, polysomnography laboratories, and pulmonary rehabilitation facilities. Results: The community new case rate should be consistently low or have a downward trajectory for at least 14 days before resuming elective clinical services. In addition, institutions should have an operational strategy that consists of patient prioritization, screening, diagnostic testing, physical distancing, infection control, and follow-up surveillance. The goals are to protect patients and staff from exposure to the virus, account for limitations in staff, equipment, and space that are essential for the care of patients with COVID-19, and provide access to care for patients with acute and chronic conditions. Conclusions: Transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a dynamic process and, therefore, it is likely that the prevalence of COVID-19 in the community will wax and wane. This will impact an institution's mitigation needs. Operating procedures should be frequently reassessed and modified as needed. The suggestions provided are those of the authors and do not represent official positions of the Association of Pulmonary, Critical Care, and Sleep Division Directors or the American Thoracic Society.
AB - In March 2020, many elective medical services were canceled in response to the coronavirus disease 2019 (COVID-19) pandemic. The daily case rate is now declining in many states and there is a need for guidance about the resumption of elective clinical services for patients with lung disease or sleep conditions. Methods: Volunteers were solicited from the Association of Pulmonary, Critical Care, and Sleep Division Directors and American Thoracic Society. Working groups developed plans by discussion and consensus for resuming elective services in pulmonary and sleep-medicine clinics, pulmonary function testing laboratories, bronchoscopy and procedure suites, polysomnography laboratories, and pulmonary rehabilitation facilities. Results: The community new case rate should be consistently low or have a downward trajectory for at least 14 days before resuming elective clinical services. In addition, institutions should have an operational strategy that consists of patient prioritization, screening, diagnostic testing, physical distancing, infection control, and follow-up surveillance. The goals are to protect patients and staff from exposure to the virus, account for limitations in staff, equipment, and space that are essential for the care of patients with COVID-19, and provide access to care for patients with acute and chronic conditions. Conclusions: Transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a dynamic process and, therefore, it is likely that the prevalence of COVID-19 in the community will wax and wane. This will impact an institution's mitigation needs. Operating procedures should be frequently reassessed and modified as needed. The suggestions provided are those of the authors and do not represent official positions of the Association of Pulmonary, Critical Care, and Sleep Division Directors or the American Thoracic Society.
KW - Covid-19
KW - Polysomnography
KW - Pulmonary function tests bronchoscopy
KW - Sars-cov-2
UR - http://www.scopus.com/inward/record.url?scp=85089970169&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089970169&partnerID=8YFLogxK
U2 - 10.1513/AnnalsATS.202005-514ST
DO - 10.1513/AnnalsATS.202005-514ST
M3 - Article
C2 - 32663071
AN - SCOPUS:85089970169
SN - 2325-6621
VL - 17
SP - 1343
EP - 1351
JO - Annals of the American Thoracic Society
JF - Annals of the American Thoracic Society
IS - 11
ER -